Fanconi-like anemia related to a FANCM mutation

Area of Science:

• Genetics
• Oncology
• Hematology

Background:

• Fanconi anemia (FA) is an autosomal recessive disorder often diagnosed late, presenting challenges in treatment.
• FA patients face an elevated risk of solid tumors, particularly in the head and neck and anogenital areas.
• Diagnosis typically involves chromosomal breakage tests, with FA gene sequencing recommended for confirmation.

Observation:

• A 32-year-old man with advanced tonsil squamous cell carcinoma experienced fatal toxicity after initial chemotherapy.
• The patient did not present with anemia, a common FA symptom.
• A novel variant in the FANCM gene (c.1511_1515delGAGTA (p.Arg504AsnfsTer29)) was identified.

Findings:

• FANCM gene variants are linked to azoospermia and primary ovarian failure, sometimes without anemia.
• Alterations in FANCM are associated with increased susceptibility to solid tumors and hematological malignancies.
• This case highlights a potential link between FANCM variants, solid tumors, and severe chemotherapy toxicity.

Implications:

• Patients with FA, particularly those with FANCM variants, exhibit hypersensitivity to DNA-damaging agents like chemotherapy and radiotherapy.
• Surgery is the preferred treatment for malignant solid tumors in FA patients.
• For FA patients requiring chemotherapy or radiotherapy, dose adjustments or alternative treatment strategies are crucial to mitigate toxicity.